Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 170, pseudogene (RN7SL170P)

Target
RN7SL170P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RN7SL170P is a processed pseudogene derived from the 7SL RNA gene. Pseudogenes are genomic elements that resemble functional genes but generally lack coding capacity or canonical biological activity[3][6]. The functional 7SL RNA is a non-coding RNA essential for the signal recognition particle (SRP) assembly, mediating the targeting of nascent secretory and membrane proteins to the endoplasmic reticulum[1][5][7]. However, pseudogenes, including RN7SL170P, typically do not encode functional RNAs or proteins and are not recognized receptors, enzymes, or drug targets. While there is growing evidence that some pseudogenes play roles in gene regulation or disease by acting as miRNA sponges or through epigenetic effects, RN7SL170P has not been implicated in these processes[4][6]. RN7SL170P is not a receptor, enzyme, transporter, or drug target. It is a member of the pseudogene and non-coding RNA families, similar in sequence to RN7SL1 (functional 7SL RNA). It does not appear in clinical, pharmacological, or disease databases as a therapeutic target, biomarker, or safety concern. Its main scientific relevance is as a molecular record of evolutionary gene duplication, not as a functional molecule. If you require structured information for computational analysis or drug targeting, RN7SL170P should be excluded from therapeutic target lists and handled as a pseudogene placeholder.

Other names
RN7SL170PRNA, 7SL, cytoplasmic 170, pseudogene
02

Biological functions

No evidence for a direct biological functionparent 7SL RNA is involved in co-translational targeting of nascent proteinsSome pseudogenes may act as regulators of their parent gene, e.g., by functioning as competing endogenous RNAs (ceRNAs) or miRNA sponges, though there is no specific evidence for RN7SL170P
03

Disease associations

No established disease roles for RN7SL170PAs with other pseudogenes, indirect regulatory or epigenetic modulation is possible but not documented for this pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 170, pseudogene (RN7SL170P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 170, pseudogene (RN7SL170P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call